Skip to main content
IDYA
NASDAQ Life Sciences

董事杰弗里·斯坦(Jeffrey Stein)购买IDEAYA Biosciences 165万美元股份

feedReported by Wiseek News
Sentiment info
Positive
Importance info
7
Price
$33.04
Mkt Cap
$2.901B
52W Low
$13.45
52W High
$39.28
Market data snapshot near publication time

summarizeSummary

IDEAYA Biosciences 董事杰弗里·斯坦(Jeffrey Stein)于2026年3月2日购买了5万股普通股,总价值约为165万美元。这一董事的大额个人投资表明了对公司未来前景的强烈信心。这次购买是在公司最近宣布2025年第四季度和全年财务报告之后发生的,包括105亿美元的巨额现金储备。交易者可能将这次内部人士的购买视为积极的指标,强化了最近的盈利报告所建立的看涨情绪。投资者将关注公司持续的运营执行和产品线进展。

在该公告发布时,IDYA的交易价格为$33.04,交易所为NASDAQ,所属行业为Life Sciences,市值约为$29亿。 52周交易区间为$13.45至$39.28。 这则新闻被评估为积极市场情绪,重要性评分为7/10。 来源:Wiseek News。


show_chartPrice Chart

Share this article

Copied!

feed IDYA - Latest Insights

IDYA
Apr 13, 2026, 6:13 AM EDT
Source: Wiseek News
Importance Score:
9
IDYA
Apr 13, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
9
IDYA
Apr 10, 2026, 5:52 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
IDYA
Apr 09, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
IDYA
Apr 06, 2026, 6:46 AM EDT
Source: Reuters
Importance Score:
8
IDYA
Mar 30, 2026, 9:09 AM EDT
Source: Reuters
Importance Score:
7
IDYA
Mar 02, 2026, 7:20 PM EST
Source: Wiseek News
Importance Score:
7
IDYA
Feb 17, 2026, 4:00 PM EST
Filing Type: 10-K
Importance Score:
8
IDYA
Feb 17, 2026, 6:04 AM EST
Filing Type: 8-K
Importance Score:
8
IDYA
Jan 12, 2026, 6:11 AM EST
Filing Type: 8-K
Importance Score:
9